Literature DB >> 12153532

Cloning and functional characterization of two glycine receptor alpha-subunits from the perch retina.

G Gisselmann1, A Galler, F Friedrich, H Hatt, J Bormann.   

Abstract

Glycine receptors are ligand-gated ion channel proteins mediating synaptic inhibition in the spinal cord, retina and brain of vertebrates. We have cloned and functionally characterized two glycine receptor alpha-subunits from the perch (Roccus americana) retina. Based on sequence homology with the mammalian counterparts, we termed these subunits alpha 1 and alpha 3. RT-PCR revealed the presence of both subunits in retina and brain, whereas alpha1 was predominant in spinal cord. A short splice variant of alpha1 was detected in the brain but not in the retina. Functional expression of the perch subunits in HEK-293 cells yielded robust glycine-gated currents sensitive to strychnine. The perch receptors displayed a high efficacy for taurine and GABA and thus differ from the mammalian counterparts. Because the retina is a rich source for taurine, this finding could be of physiological importance. The structural features of the ligand binding domain strongly support the notion of increased glycine/GABA discrimination in higher vertebrates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153532     DOI: 10.1046/j.1460-9568.2002.02070.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  3 in total

1.  Caffeine inhibition of ionotropic glycine receptors.

Authors:  Lei Duan; Jaeyoung Yang; Malcolm M Slaughter
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

2.  Protein kinases regulate glycine receptor binding in brain stem auditory nuclei after unilateral cochlear ablation.

Authors:  Leqin Yan; Sanoj K Suneja; Steven J Potashner
Journal:  Brain Res       Date:  2007-01-02       Impact factor: 3.252

3.  Effects of dietary taurine level on visual function in European sea bass (Dicentrarchus labrax).

Authors:  Richard W Brill; Andrij Z Horodysky; Allen R Place; Mary E M Larkin; Renate Reimschuessel
Journal:  PLoS One       Date:  2019-06-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.